Cytomedix Says Wound-Healing 510(k) Will Help Its Case With Medicare
Cytomedix's hard-won FDA clearance of its wound-healing device will lend strength to the company's pursuit of national Medicare coverage, the firm says
Cytomedix's hard-won FDA clearance of its wound-healing device will lend strength to the company's pursuit of national Medicare coverage, the firm says